GFAP+ astrocyte coverage was not significantly increased in MS compared to controls (MS: 0.85 ± 0.39 million pixels/mm2 vs. control: 0.84 ± 0.43 million pixels/mm2, p = 0.583). The gene discussed is GFAP; the disease is myeloid sarcoma.